Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression

Targeting the Immune system and Epigenetic Landscape of Urological Tumors

(2020) João Lobo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions

(2020) Sara Monteiro-Reis et al.   Journal of Clinical Medicine

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer

(2019) Sara Monteiro-Reis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer

(2019) Patrice Hodonou Avogbe et al.   EBioMedicine

E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients

(2019) João Lobo et al.   MODERN PATHOLOGY

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment

(2019) Ekaterina Blinova et al.   Cells

Molecular subtypes and response to immunotherapy in bladder cancer patients

(2019) Tilman Todenhöfer et al.   Translational Andrology and Urology

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

(2019) Aurélie Kamoun et al.   EUROPEAN UROLOGY

Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features

(2018) Catarina Ferreira et al.   VIRCHOWS ARCHIV

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort

(2018) Nour-al-dain Marzouka et al.   Scientific Reports

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

(2018) A. Gordon Robertson et al.   CELL

Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors

(2018) Tuan Zea Tan et al.   EUROPEAN UROLOGY

Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?

(2018) Lars Dyrskjøt   EUROPEAN UROLOGY

Molecular Subtypes of Bladder Cancer

(2018) David J. McConkey et al.   Current Oncology Reports

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

(2018) Anushka Dongre et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

Bladder cancer

(2017) Oner Sanli et al.   Nature Reviews Disease Primers

Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition

(2016) Joseph Sanfrancesco et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Molecular Subtypes of Non-muscle Invasive Bladder Cancer

(2016) Seth P. Lerner et al.   CANCER CELL

Novel therapeutic targets in advanced urothelial carcinoma

(2016) Mathieu Rouanne et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

(2016) Jonathan E Rosenberg et al.   LANCET

Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy

(2016) Francesco Piva et al.   Molecular Diagnosis & Therapy

Characteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression

(2016) YANG LUO et al.   Oncology Letters

Update on the management of non-muscle invasive bladder cancer

(2016) Saad Aldousari et al.   CUAJ-Canadian Urological Association Journal

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

(2014) Thomas Powles et al.   NATURE

Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena

(2014) R. T. Bryan   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer

(2014) Jun Zhao et al.   International Braz J Urol

Epithelial mesenchymal transition in urothelial carcinoma: Twist in the tale

(2013) Purnima Paliwal et al.   Indian Journal of Pathology and Microbiology

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome

(2010) David Lindgren et al.   CANCER RESEARCH

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

(2008) S Al-Saad et al.   BRITISH JOURNAL OF CANCER